Vital Chemtech Limited (VITAL) fundamentals
Vital Chemtech Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as VITAL (ISIN INE0L4K01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Vital Chemtech Limited does
Vital Chemtech Limited is an India-based manufacturer of phosphorus derivatives. The Company is engaged in the business of manufacturing and supplying phosphorus derivatives, specialty chemicals, organic chemicals, heavy chemicals, and various intermediates for life sciences and crop protection. The Company's product portfolio includes Phosphorus Derivatives, Industrial Chemicals, Specialty Chemicals and Intermediates, Organophosphates, Polymers and Dispersants, and Wellness Products. Its Phosphorus Derivatives products include phosphorus trichloride (PCl3), phosphorus oxychloride (POCl3), phosphorus pentachloride (PCl5), phosphorus pentoxide (P2O5), poly phosphoric acid (PPA), and phosphorus pentasulfide (P2S5). The Company offers a range of wellness products in the form of tablets, capsules, oral powder and effervescent tablets for protein support, sugar control, support nutrition, cognitive health and mental health, and performance and fertility.
Valuation and market data
| Last close | ₹55.67 |
|---|---|
| Market capitalisation | ₹134 crore |
| Enterprise value | ₹174 crore |
| P/E (TTM) | 0.00 |
| Price to book | 1.44 |
| Price to sales (TTM) | 0.91 |
| Book value per share | ₹38.61 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Wed Mar 11 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹114 crore | ₹10 crore | ₹9 crore | 0.00 |
| Mar 2025 | ₹122 crore | ₹7 crore | ₹5 crore | 1.93 |
| Mar 2024 | ₹105 crore | ₹5 crore | ₹4 crore | 1.68 |
| Mar 2023 | ₹117 crore | ₹11 crore | ₹8 crore | 4.50 |
| Mar 2022 | ₹58 crore | ₹11 crore | ₹8 crore | 11.75 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 73.4% |
|---|---|
| Foreign institutions (FII) | 1.6% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.3% |
| Retail and others | 24.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.